GNYSEServices-Management Consulting ServicesFiscal year ends December 31
Genpact LTD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$37.68+0.42 (+1.13%)
Close on Oct 19, 2026
- Market cap
- $6.42B
- P/E (TTM)
- 11.2
- Dividend yield
- 1.80%
Genpact LTD revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High Tech and Manufacturing | $2.00B | $1.79B | $1.68B | $1.62B | $1.49B | $1.39B | – | – | – | – | 39.3% | +11.9% |
| Consumer and Healthcare | $1.72B | $1.69B | $1.57B | $1.59B | $1.52B | $1.26B | – | – | – | – | 34.0% | +1.9% |
| Financial Services | $1.36B | $1.29B | $1.23B | $1.16B | $1.02B | $1.08B | – | – | – | – | 26.7% | +5.3% |
| Information technology services | – | – | – | – | – | – | – | – | $472.59M | $487.31M | – | – |
| Business process outsourcing | – | – | – | – | – | – | – | – | $2.26B | $2.08B | – | – |
| High Tech and Manufacturing | – | – | – | – | $1.48B | $1.39B | $1.35B | – | – | – | – | – |
| CGRLH | – | – | – | – | $1.51B | $1.26B | $1.11B | – | – | – | – | – |
| BCMI | – | – | – | – | $1.02B | $1.08B | $1.08B | – | – | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Core Business Services | $3.88B | $3.74B | $3.49B | – | – | – | – | – | – | – | 76.3% | +3.7% |
| Digital Operations | $2.64B | $2.53B | $2.39B | $2.32B | $2.33B | $2.34B | – | – | – | – | 51.9% | +4.1% |
| Data-Tech-AI | $2.44B | $2.23B | $2.09B | $2.05B | $1.69B | $1.39B | – | – | – | – | 48.1% | +9.3% |
| Advanced Technology Solutions | $1.20B | $1.03B | $984.71M | – | – | – | – | – | – | – | 23.7% | +17.0% |
| Business process outsourcing | – | – | – | – | – | – | $2.97B | $2.50B | $2.26B | $2.08B | – | – |
| Information technology services | – | – | – | – | – | – | $546.33M | $497.98M | $472.59M | $487.31M | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India | $2.98B | $2.76B | $2.32B | $2.28B | $2.02B | $1.85B | $1.89B | $1.74B | $1.71B | $1.80B | 58.7% | +8.0% |
| Asia, other than India | $788.06M | $700.26M | $643.10M | $551.47M | $536.60M | $461.84M | $356.73M | $327.46M | $286.34M | $249.84M | 15.5% | +12.5% |
| North and Latin America | $730.44M | $683.41M | $979.95M | $1.07B | $1.01B | $1.01B | $863.75M | $641.72M | $455.06M | $282.43M | 14.4% | +6.9% |
| Europe | $578.40M | $621.92M | $532.99M | $471.48M | $451.73M | $388.56M | $409.17M | $292.16M | $282.75M | $234.37M | 11.4% | -7.0% |
| Banking, Financial Services and Insurance | – | – | – | – | – | – | – | – | $1.11B | $1.06B | – | – |
| Technology, healthcare and other services | – | – | – | – | – | – | – | – | $628.23M | $556.27M | – | – |
| Manufacturing including pharmaceuticals and medical equipment manufacturing | – | – | – | – | – | – | – | – | $1.00B | $958.78M | – | – |
From the segment and revenue-disaggregation notes of Genpact's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.